Tenofovir disoproxil succinate
Especificaciones
1637632-97-3Número CAS
[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-(propan-2-yloxycarbonyloxymethoxy)phosphoryl]oxymethyl propan-2-yl carbonate;butanedioic acidNombre IUPAC
C23H36N5O14PFórmula química
637.5 g/molPeso molecular
Tenofovir disoproxil succinate; UNII-94882WB39E; 1637632-97-3; 94882WB39E; 2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-(((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-, 1,9-bis(1-methylethyl) ester, 5-oxide, butanedioate (1:1); TENOFOVIR DISOPROXIL SUCCINATE [WHO-DD]; RefChem:203222; SCHEMBL984685; Q27271655Sinónimos
Productos que contienen Tenofovir disoproxil succinate
EMTRICITABINA/TENOFOVIR DISOPROXILO KRKA 200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGEFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO KRKA 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGEFAVIRENZ/EMTRICITABINA/TENOFOVIR DISOPROXILO DR REDDYS 600 MG/200 MG/245 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGTENOFOVIR DISOPROXIL EG 245 mg, comprimé pelliculéTENOFOVIR DISOPROXIL BIOGARAN 245 mg, comprimé pelliculéEMTRICITABINE/TENOFOVIR DISOPROXIL KRKA D.D. 200 mg/245 mg, comprimé pelliculéEMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 200 mg/245 mg, comprimé pelliculéEMTRICITABINE/TENOFOVIR DISOPROXIL EVOLUGEN 200 mg/245 mg, comprimé pelliculéEMTRICITABINE/TENOFOVIR DISOPROXIL EG 200 mg/245 mg, comprimé pelliculéEMTRICITABINE/TENOFOVIR DISOPROXIL BIOGARAN 200 mg/245 mg, comprimé pelliculéEFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL KRKA 600 mg/200 mg/245 mg, comprimé pelliculéTenofovir Disoproxil Succinate - Zhejiang Jiuzhou Pharmaceutical
Página 1 de 2
